Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endocare Inc (ENDO.PK) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Endocare Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1003464.
Total stock buying since 2006: $1,970,900.
Total stock sales since 2006: $298,423.
Total stock option exercises since 2006: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 0 | $0 | 482,011 | $0 |
| 2008 | 158,842 | $873,211 | 558,548 | $298,423 | 95,493 | $0 |
| 2007 | 145,667 | $968,290 | 0 | $0 | 46,093 | $0 |
| 2006 | 64,000 | $129,399 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-07 | 0 | $0 | 0 | $0 | 411,115 | $0 |
| 2009-05 | 0 | $0 | 0 | $0 | 28,568 | $0 |
| 2009-04 | 0 | $0 | 0 | $0 | 25,872 | $0 |
| 2009-03 | 0 | $0 | 0 | $0 | 6,156 | $0 |
| 2009-01 | 0 | $0 | 0 | $0 | 10,300 | $0 |
| 2008-12 | 0 | $0 | 550,836 | $265,163 | 0 | $0 |
| 2008-07 | 40,776 | $141,737 | 5,275 | $20,630 | 0 | $0 |
| 2008-06 | 7,309 | $36,369 | 2,437 | $12,630 | 0 | $0 |
| 2008-04 | 49,069 | $294,463 | 0 | $0 | 0 | $0 |
| 2008-03 | 0 | $0 | 0 | $0 | 51,048 | $0 |
| 2008-02 | 0 | $0 | 0 | $0 | 44,445 | $0 |
| 2008-01 | 61,688 | $400,642 | 0 | $0 | 0 | $0 |
| 2007-12 | 116,667 | $904,169 | 0 | $0 | 0 | $0 |
| 2007-08 | 29,000 | $64,121 | 0 | $0 | 0 | $0 |
| 2007-02 | 0 | $0 | 0 | $0 | 46,093 | $0 |
| 2006-09 | 13,000 | $28,158 | 0 | $0 | 0 | $0 |
| 2006-08 | 51,000 | $101,241 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-07-27 | Davis Clint (Other) | Option Ex | 46,156 | .00 | 0 |
| 2009-07-27 | Rodriguez Michael R (Other) | Option Ex | 50,000 | .00 | 0 |
| 2009-07-27 | Daniels John R (Other) | Option Ex | 53,423 | .00 | 0 |
| 2009-07-27 | Quilty Kevin M (Other) | Option Ex | 36,667 | .00 | 0 |
| 2009-07-27 | Goldsmith David L (Other) | Option Ex | 94,457 | .00 | 0 |
| 2009-07-27 | Testman Thomas R (Other) | Option Ex | 62,360 | .00 | 0 |
| 2009-07-27 | Kentor Eric S (Other) | Option Ex | 68,052 | .00 | 0 |
| 2009-05-15 | Daniels John R (Director) | Option Ex | 7,142 | .00 | 0 |
| 2009-05-15 | Goldsmith David L (Director) | Option Ex | 7,142 | .00 | 0 |
| 2009-05-15 | Testman Thomas R (Director) | Option Ex | 7,142 | .00 | 0 |
| 2009-05-15 | Kentor Eric S (Director) | Option Ex | 7,142 | .00 | 0 |
| 2009-04-06 | Noonan Terrence A (Other) | Option Ex | 25,872 | .00 | 0 |
| 2009-03-03 | Davis Clint (General Counsel) | Option Ex | 6,156 | .00 | 0 |
| 2009-01-10 | Daniels John R (Director) | Option Ex | 2,060 | .00 | 0 |
| 2009-01-10 | Noonan Terrence A (Interim CEO/President) | Option Ex | 2,060 | .00 | 0 |
| 2009-01-10 | Goldsmith David L (Director) | Option Ex | 2,060 | .00 | 0 |
| 2009-01-10 | Testman Thomas R (Director) | Option Ex | 2,060 | .00 | 0 |
| 2009-01-10 | Kentor Eric S (Director) | Option Ex | 2,060 | .00 | 0 |
| 2008-12-30 | Andreeff Equity Advisors, Llc (10% Owner) | Sale | 420,836 | .47 | 198,213 |
| 2008-12-29 | Andreeff Equity Advisors, Llc (10% Owner) | Sale | 130,000 | .52 | 66,950 |
| 2008-07-31 | Andreeff Dane (10% Owner) | Buy | 40,776 | 3.48 | 141,737 |
| 2008-07-18 | Andreeff Dane (10% Owner) | Sale | 5,275 | 3.91 | 20,630 |
| 2008-06-30 | Andreeff Dane (10% Owner) | Buy | 7,309 | 4.98 | 36,369 |
| 2008-06-23 | Andreeff Dane (10% Owner) | Sale | 2,437 | 5.18 | 12,630 |
| 2008-04-30 | Andreeff Dane (10% Owner) | Buy | 49,069 | 6.00 | 294,463 |
| 2008-03-06 | Davis Clint (SVP, Lgl Affairs & Gen'l Cnsl) | Option Ex | 17,153 | .00 | 0 |
| 2008-03-06 | Rodriguez Michael R (SVP, Finance and CFO) | Option Ex | 4,031 | .00 | 0 |
| 2008-03-06 | Davenport Craig T (Chairman, CEO and President) | Option Ex | 29,864 | .00 | 0 |
| 2008-02-23 | Davenport Craig T (Chairman, CEO and President) | Option Ex | 44,445 | .00 | 0 |
| 2008-01-30 | Fhm V, Lp (10% Owner) | Buy | 3,084 | 6.91 | 21,310 |
| 2008-01-29 | Fhm V, Lp (10% Owner) | Buy | 2,600 | 6.95 | 18,057 |
| 2008-01-28 | Fhm V, Lp (10% Owner) | Buy | 200 | 6.35 | 1,270 |
| 2008-01-25 | Fhm V, Lp (10% Owner) | Buy | 3,006 | 6.40 | 19,238 |
| 2008-01-24 | Fhm V, Lp (10% Owner) | Buy | 34,130 | 6.46 | 220,342 |
| 2007-12-12 | Fhm V, Lp (10% Owner) | Buy | 116,667 | 7.75 | 904,169 |
| 2007-08-23 | Davenport Craig T (CEO, President & Chairman) | Buy | 500 | 7.50 | 3,750 |
| 2007-08-16 | Daniels John R (Director) | Buy | 15,000 | 2.05 | 30,749 |
| 2007-08-16 | Testman Thomas R (Director) | Buy | 6,500 | 2.04 | 13,292 |
| 2007-08-16 | Kentor Eric S (Director) | Buy | 2,000 | 1.99 | 3,980 |
| 2007-08-10 | Kentor Eric S (Director) | Buy | 5,000 | 2.47 | 12,350 |
| 2007-02-21 | Davis Clint (SVP, Lgl Affairs & Gen'l Cnsl) | Option Ex | 23,376 | .00 | 0 |
| 2007-02-21 | Rodriguez Michael R (SVP, Finance and CFO) | Option Ex | 3,473 | .00 | 0 |
| 2007-02-21 | Davenport Craig T (Chairman, President & CEO) | Option Ex | 19,244 | .00 | 0 |
| 2006-09-01 | Davenport Craig T (Chairman & CEO) | Buy | 13,000 | 2.17 | 28,158 |
| 2006-08-31 | Davenport Craig T (Chairman & CEO) | Buy | 15,500 | 2.02 | 31,387 |
| 2006-08-30 | Kentor Eric S (Director) | Buy | 7,000 | 2.05 | 14,349 |
| 2006-08-29 | Testman Thomas R (Director) | Buy | 1,500 | 2.10 | 3,150 |
| 2006-08-28 | Testman Thomas R (Director) | Buy | 5,000 | 2.08 | 10,375 |
| 2006-08-25 | Testman Thomas R (Director) | Buy | 2,000 | 1.99 | 3,980 |
| 2006-08-23 | Davenport Craig T (Chairman & CEO) | Buy | 20,000 | 1.90 | 38,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENDO.PK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endocare Inc (symbol ENDO.PK, CIK number 1003464) see the Securities and Exchange Commission (SEC) website.